kaal:position:2026-07-31-1338

Dynamic Regulation of Phosphoinositide 3-Kinase- (cid:1) Activity and (cid:2) -Adrenergic Receptor Trafficking in End-Stage Human Heart Failure Heart Failure should be assessed against Kaal's source-bound claim that The three core law and technology proposals for the pacing problem, regulation via the judiciary, early stage regulation of innovation, and principles based regulation, all have practical limitations and none of them uses dynamic regulatory elements. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

Apply only within the source-bound Kaal claim's stated scope.
External evidence level: metadata only.
Mapping review tier: mapping review before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Dynamic Regulation of Phosphoinositide 3-Kinase- (cid:1) Activity and (cid:2) -Adrenergic Receptor Trafficking in End-Stage Human Heart Failure Heart Failure

Scholarly basis

kaal:claim:2831040-015
Wulf A. Kaal, Dynamic Regulation for Innovation (2016). SSRN: https://ssrn.com/abstract=2831040
Source PDF sha256: de5156f14f44a5753cab55b6c4b03049eda58a143b99e08ef427aee1d261e1bf

Evidence and mapping

Evidence: metadata only
Review tier: mapping review before claim review
Mapping confidence: 0.3218
Mapping ambiguous: true

Topics

dynamic-regulation

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0006 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: 082f5d097f21e8096ba3eed9dde44b8aadd14b60ba62fb840187a8813d3c6e51
curl -s https://wulfkaal.github.io/positions/2026-07-31-1338.md | sha256sum